Publications
Peer-Reviewed Publications:
1. Cajiao I, Sargent R, Elstrom R, Cooke NE, Bagg A, Liebhaber SA. Igβ(CD79b)mRNA expression in chronic lymphocytic leaukemia cells correlates with immunoglobulin heavy chain gene mutational status but does not serve as an independent predictor of clinical severity, American Journal of Hematology. 82(8):712-20, 2007.
2. Roullet M, Sargent R, Pasha T, Cajiao I, Elstrom R, Smith T, Liebhaber S, Zhang P, Bagg A. "ZAP70 Expression Assessed by Immunohistochemistry on Peripheral Blood: A Simple Prognostic Assay for Patients with Chronic Lymphocytic Leukemia," Applied Immunohistochemistry and Molecular Morphology. 15(4):471-6, 2007.
3. Alinari L, Castellucci P, Elstrom R, Ambrosini V, Stefoni V, Nanni C, Berkowitz A, Tani M, Farsad M, Franchi R, Fanti S, Zinzani PL. 18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma, Leukemia and Lymphoma, 47(10): 2096-101, 2006.
4. Frey NV, Svoboda J, Andreadis C, Tsai DE, Schuster SJ, Elstrom R, Rubin SC, Nasta SD. Primary lymphomas of the cervix and uterus: the University of Pennsylvanias experience and a review of literature, Leukemia and Lymphoma, 47(9): 1894-901, 2006.
5. Svoboda J, Andreadis C, Elstrom R, Chong EA, Downs LH, Berkowitz A, Luger SM, Porter DL, Nasta S, Tsai D, Loren AW, Siegel DL, Glatstein E, Alavi A, Stadtmauer EA, Schuster SJ. "Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation," Bone Marrow Transplant, 38(3):211-6, 2006
6. Elstrom RL, Andreadis C, Aqui NA, Ahya VN, Bloom RD, Brozena SC, Olthoff KM, Schuster SJ, Nasta SD, Stadtmauer EA, Tsai DE, Treatment of PTLD with Rituximab or Chemotherapy, American Journal of Transplantation, 6(3): 569-576, 2006.
7. Andreadis C, Schuster SJ, Chong EA, Svoboda J, Luger SM, Porter DL, Tsai DE, Nasta SD, Elstrom RL, Goldstein SC, Downs LH, Mangan PA, Cunningham KA, Hummel KA, Gimotty PA, Siegel DL, Glatstein E, Stadtmauer EA, Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma, Bone Marrow Transplant, 36 (11): 955-961, 2005.
8. Vogl DT, Glatstein E, Carver JR, Schuster SJ, Stadtmauer EA, Luger S, Nasta SD, Porter DL, Elstrom R, Tsai DE, Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation, Leukemia and Lymphoma, 46(9): 1313-1320, 2005.
9. Buzzai M, Bauer DE, Jones RG, DeBerardinis RJ, Elstrom RL, and Thompson CB, AMPK induction of fatty acid b-oxidation is required to reverse the glucose dependence of Akt-transformed cells, Oncogene, 24(26):4165-4173, 2005.
10. Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang HM, Cinalli RM, Alavi A, Rudin CM, Thompson CB; Akt stimulates aerobic glycolysis in cancer cells. Cancer Research 64(11): 3892-3899, 2004.
11. Elstrom RL, Tsai D, Alavi A, Vergilio J, Downs L, Schuster SJ;Enhanced marrow FDG uptake related to cytokine induced myeloid hyperplasia by Hodgkins lymphoma can simulate marrow involvement by lymphoma: implications for interpretation of FDG-PET imaging in clinical staging. Clinical Lymphoma, 5: 62-64, 2004.
12. Rathmell JC, Elstrom RL, Cinalli RM, Thompson CB. Activated Akt promotes increased resting T cell size, CD-28-independent T cell growth, and development of autoimmunity and lymphoma. Eur J Immunol,, 33(8): 2223-2232, 2003.
13. Elstrom RL, Guan L, Pitsilos S, Bagg A, Downs L, Alavi A, and Schuster SJ, "Utility of 18FDG-PET scanning in lymphoma by WHO classification." Blood, 101: 3875-3876, 2003.
14. Frauwirth KA, Riley JL, Parry RV, Rathmell JC, Harris MH, Plas DR, Elstrom RL, June CH, and Thompson CB; "CD28 costimulation enhances T lymphocyte glucose metabolism via PI3K/Akt signaling." Immunity, 16: 769-777, 2002.
15. Villablanca J, Anderson J, Moseley M, Law C-L, Elstrom R, LeBien T; Differentiation of Normal Human Pre-B Cells in Vitro. J. Exp. Med., 172: 325-334, 1990.
16. LeBien T, Elstrom R, Moseley M, Kersey J, Griesinger F; Analysis of immunoglobulin and T-cell receptor gene rearrangements in human fetal bone marrow B lineage cells. Blood. 76: 1196-1200, 1990.
Non-Peer Reviewed Publications and Book Chapters:
1. Elstrom RL and Thompson CB; "Cell life and Cell Death." Clinical Oncology 4th edition, ed. Abeloff M, Armitage J, Kastan M, Niederhuber J; in press.
2. Elstrom R, "Positron emission tomography in Hodgkin's lymphoma." Haematologica, 91(4): 435, 2006.
3. Elstrom RL; The Appropriate Use of PET and Gallium Scans in Lymphoma. Clinical Malignant Hematology, ed. Sekeres MA, Kalaycio ME, and Bolwell BJ, 2007.
4. Elstrom RL and Thompson CB; Cell life and cell death. Clinical Oncology 3rd edition, ed. Abeloff M, Armitage J, Kastan M, Niederhuber J; 2003.
5. Elstrom RL and Thompson CB; "Influencing the Apoptotic Mechanism in Cancer Treatment." Progress in Oncology, p.72-90, ed. DeVita V, Hellman S, Rosenberg S, 2001.
